Top Pediatric HIV/AIDS Drug to be Offered by AbbVie for Generics Manufacture

Heeding call to ‘Focus, Partner and Achieve’, long-term shareholders are gratified by company’s decision to open access and cut costs of life-saving medicines for the world’s most vulnerable children NEW YORK, NY – MONDAY, DECEMBER 1, 2014 – Shareholders and members of the Interfaith Center on Corporate Responsibility (ICCR)  who have long advocated for IP-sharing … Continue reading Top Pediatric HIV/AIDS Drug to be Offered by AbbVie for Generics Manufacture